Cancer BiologybioRxivPreprint
EZH2 inhibition enhances TRAIL responses in multiple myeloma but not in quiescent cells
A. Arhoma, J. Southan, A. D. Chantry…·N. A. Cross
This study shows that EZH2 inhibition with GSK343 enhances TRAIL-induced apoptosis in multiple myeloma cell lines and 3D cultures, but not in TRAIL-resistant or quiescent cells.
DOI 10.1101/2021.07.23.453217